Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for Sanofi (SNY)

Detailed Quote for Sanofi (SNY)

Sector News | Topic News
News for Sanofi (SNY)
Wed, May 22, 2019
8:35 PM Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019 - SeekingAlpha
1:11 PM Mallinckrodt: Assessing A Possible Turnaround - SeekingAlpha
Tue, May 21, 2019
8:39 AM Alphabet teams with Pfizer, Novartis on clinical trials - SeekingAlpha
Sat, May 18, 2019
11:10 AM Sanofi: A Robust Pharma Giant With Strong Growth In Q1 - SeekingAlpha
Fri, May 17, 2019
7:49 PM ImmunoGen: Assessing The Possibility Of A Turnaround - SeekingAlpha
Thu, May 16, 2019
8:07 AM Regeneron and Sanofi's Libtayo shows positive effect in mid-stage skin cancer study - SeekingAlpha
Wed, May 15, 2019
5:00 PM Sanofi oncology pipeline targeting various cancers highlighted at ASCO 2019 - PR Newswire
Mon, May 13, 2019
2:11 AM How Regeneron Can Take Its Sad Song And Make It (Much) Better - SeekingAlpha
Wed, May 08, 2019
7:54 PM Kiplinger's May List Of Most Reliable Dividend Stocks On Earth - SeekingAlpha
8:45 AM Sanofi Announces Licensing of Dupixent\u00AE ? (dupilumab) in the EU for the Treatment of Severe Asthma With Type 2 Inflammation[1] - PR Newswire
Tue, May 07, 2019
2:35 PM NextCure IPO: The Enterprise Value Could Increase In 2020 - SeekingAlpha
Fri, May 03, 2019
6:39 AM FDA OKs AstraZeneca's combo pill for T2D - SeekingAlpha
Thu, May 02, 2019
9:22 AM Lexicon Pharmaceuticals Languishing In The Dog House - SeekingAlpha
6:55 AM FDA OKs Sanofi's dengue vaccine - SeekingAlpha
Wed, May 01, 2019
6:35 PM FDA approves Dengvaxia\u00AE for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas - PR Newswire
Fri, Apr 26, 2019
7:59 PM Sanofi S.A. (SNY) CEO Olivier Brandicourt on Q1 2019 Results - Earnings Call Transcript - SeekingAlpha
10:52 AM Key events next week - healthcare (Part 1) - SeekingAlpha
8:35 AM Sanofi 2019 Q1 - Results - Earnings Call Slides - SeekingAlpha
8:05 AM Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER - PR Newswire
6:29 AM Sanofi top line up 6% in Q1 - SeekingAlpha
More News for SNY >>